182 related articles for article (PubMed ID: 30995126)
1. Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Krawczyk MA; Styczewska M; Sokolewicz EM; Kunc M; Gabrych A; Fatyga A; Izycka-Swieszewska E; Kazanowska B; Adamkiewicz-Drozynska E; Bien E
Biomarkers; 2019 Sep; 24(6):538-548. PubMed ID: 30995126
[No Abstract] [Full Text] [Related]
2. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
Dungwa JV; Hunt LP; Ramani P
BMC Cancer; 2011 Sep; 11():390. PubMed ID: 21910893
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of significance of Hypoxia Inducible Factor-1α, Glucose Transporter-1 and Carbonic Anhydrase IX in rectal cancer after preoperative chemoradiotherapy.
Vitoratou DI; Tolia M; Liakos P; Tsoukalas N; Giaginis C; Nikolaou M; Nikolaou G; Rigas G; Psarianos K; Lioupis A; Kyrgias G
J BUON; 2019; 24(2):456-463. PubMed ID: 31127991
[TBL] [Abstract][Full Text] [Related]
4. Expression of HIF-1α in medullary thyroid cancer identifies a subgroup with poor prognosis.
Lodewijk L; van Diest P; van der Groep P; Ter Hoeve N; Schepers A; Morreau J; Bonenkamp J; van Engen-van Grunsven A; Kruijff S; van Hemel B; Links T; Nieveen van Dijkum E; van Eeden S; Valk G; Borel Rinkes I; Vriens M
Oncotarget; 2017 Apr; 8(17):28650-28659. PubMed ID: 28404916
[TBL] [Abstract][Full Text] [Related]
5. Expression of carbonic anhydrase IX in craniopharyngiomas.
Proescholdt M; Merrill M; Stoerr EM; Lohmeier A; Dietmaier W; Brawanski A
J Neurosurg; 2011 Oct; 115(4):796-801. PubMed ID: 21761968
[TBL] [Abstract][Full Text] [Related]
6. Is the hypoxia-inducible factor pathway important in gastric cancer?
Griffiths EA; Pritchard SA; Welch IM; Price PM; West CM
Eur J Cancer; 2005 Dec; 41(18):2792-805. PubMed ID: 16290133
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
8. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
10. Expression of endogenous hypoxia markers in vulvar squamous cell carcinoma.
Li YZ; Li SL; Li X; Wang LJ; Wang JL; Xu JW; Wu ZH; Gong L; Zhang XD
Asian Pac J Cancer Prev; 2012; 13(8):3675-80. PubMed ID: 23098453
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases.
Rajaganeshan R; Prasad R; Guillou PJ; Scott N; Poston G; Jayne DG
Eur J Surg Oncol; 2009 Dec; 35(12):1286-94. PubMed ID: 19540709
[TBL] [Abstract][Full Text] [Related]
12. Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels.
Campbell EJ; Dachs GU; Morrin HR; Davey VC; Robinson BA; Vissers MCM
BMC Cancer; 2019 Apr; 19(1):307. PubMed ID: 30943919
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
14. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW
Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490
[TBL] [Abstract][Full Text] [Related]
16. Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation.
Jensen R; Lee J
Neurosurgery; 2012 Jul; 71(1):146-56. PubMed ID: 22472549
[TBL] [Abstract][Full Text] [Related]
17. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E
J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538
[TBL] [Abstract][Full Text] [Related]
18. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
19. Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor.
Karpinsky G; Krawczyk MA; Izycka-Swieszewska E; Fatyga A; Budka A; Balwierz W; Sobol G; Zalewska-Szewczyk B; Rychlowska-Pruszynska M; Klepacka T; Dembowska-Baginska B; Kazanowska B; Gabrych A; Bien E
J Cancer Res Clin Oncol; 2018 Mar; 144(3):519-529. PubMed ID: 29332262
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy.
Lee-Kong SA; Ruby JA; Chessin DB; Pucciarelli S; Shia J; Riedel ER; Nitti D; Guillem JG
Dis Colon Rectum; 2012 Sep; 55(9):990-5. PubMed ID: 22874607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]